Skip to main content
. 2021 Sep 18;14(18):5401. doi: 10.3390/ma14185401

Figure 1.

Figure 1

The 2-amino-4-aryl-3,5-dicarbonitrile-6-sulfanylpyridines as medicinally privileged structures.